Skip to main content
SpringerLink
Log in

Evaluation and Treatment of Peyronie’s Disease

  • Chapter
  • First Online:
Urological Men’s Health

Part of the book series: Current Clinical Urology ((CCU))

  • 789 Accesses

Abstract

Peyronie’s disease is a common potency-threatening condition of male sexual dysfunction, occurring in 3–8% of men. While typically thought to be a result of injury during sexual activity, the underlying cause of Peyronie’s disease can vary and is not known in every situation. Clinical presentation may include a curved or bent penis, a palpable penile scar or plaque, complaints of decreased penile length, diminished penile stretch, less rigidity, penile numbness, and erectile dysfunction. Numerous advances have been made in understanding the mechanisms involving Peyronie’s disease, while improved diagnostic techniques, including penile duplex Doppler ultrasonography, and advanced therapeutic interventions, including intralesional therapy, surgical grafting techniques, and advanced prosthetics have allowed for the successful treatment of this significant medical problem. This chapter reviews the contemporary state of knowledge of Peyronie’s disease, focusing on the role of diagnostics, therapeutic alternatives and offers an algorithmic approach for the management of this disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Serefoglu EC, Hellstrom WJ. Treatment of Peyronie’s disease: 2012 update. Curr Urol Rep. 2011;12(6):444–52. http://dx.doi.org/10.1007/s11934-011-0212-2aaaa. Accessed 5 Aug 2011.

    Article  PubMed  Google Scholar 

  2. Nugteren HM, Nijman JM, de Jong IJ, van Driel MF. The association between Peyronie’s and Dupuytren’s disease. Int J Impot Res. 2011;23(4):142–5.

    Article  PubMed  CAS  Google Scholar 

  3. Casabé A, Bechara A, Cheliz G, De Bonis W, Rey H. Risk factors of Peyronie’s disease. What does our clinical experience show? J Sex Med. 2011;8(2):518–23.

    Article  PubMed  Google Scholar 

  4. Faix A, Lapray JF, Callede O, Maubon A, Lanfrey K. Magnetic resonance imaging (MRI) of sexual intercourse: second experience in missionary position and initial experience in posterior position. J Sex Marital Ther. 2002;28 Suppl 1:63–76.

    Article  PubMed  Google Scholar 

  5. Hellstrom WJ, Bivalacqua TJ. Peyronie’s disease: etiology, medical, and surgical therapy. J Androl. 2000; 21(3):347–54.

    PubMed  CAS  Google Scholar 

  6. Hakim LS, Platt M. The couple’s disease: finding a cure for your ‘lost’ love life. NY: DHP Publishers; 2002.

    Google Scholar 

  7. Mulhall JP, Alex B, Choi JM. Predicting delay in presentation in men with Peyronie’s disease. J Sex Med. 2010;7(6):2226–30.

    Article  PubMed  Google Scholar 

  8. Smith JF, Brant WO, Fradet V, Shindel AW, et al. Penile sonographic and clinical characteristics in men with Peyronie’s disease. J Sex Med. 2009;6(10): 2858–67.

    Article  PubMed  Google Scholar 

  9. Smith JF, Walsh TJ, Conti SL, Turek P, Lue T. Risk factors for emotional and relationship problems in Peyronie’s disease. J Sex Med. 2008;5(9):2179–84.

    Article  PubMed  Google Scholar 

  10. Ralph D, Gonzalez-Cadavid N, Mirone V, Perovic S, Sohn M, Usta M, Levine L. The management of Peyronie’s disease: evidence-based 2010 guidelines. J Sex Med. 2010;7(7):2359–74.

    PubMed  Google Scholar 

  11. Gur S, Limin M, Hellstrom WJ. Current status and new developments in Peyronie’s disease: medical, minimally invasive and surgical treatment options. Expert Opin Pharmacother. 2011;12(6):931–44.

    Article  PubMed  Google Scholar 

  12. Safarinejad MR, Asgari MA, Hosseini SY, Dadkhah F. A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie’s disease. BJU Int. 2010;106(2):240–8.

    Article  PubMed  CAS  Google Scholar 

  13. Gonzalez-Cadavid NF, Rajfer J. Treatment of Peyronie’s disease with PDE5 inhibitors: an antifibrotic strategy. Nat Rev Urol. 2010;7(4): 215–21.

    Article  PubMed  CAS  Google Scholar 

  14. Chung E, Deyoung L, Brock GB. The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomes. J Sex Med. 2011;8(5):1472–7.

    Article  PubMed  CAS  Google Scholar 

  15. Cavallini G, Biagiotti G, Lo Giudice C. Association between Peyronie’s disease and low serum testosterone levels: detection and therapeutic considerations. J Androl. 2011. http://www.andrologyjournal.org/cgi/rapidpdf/jandrol.111.012948v1. Accessed 5 Aug 2011.

  16. Greenfield JM, Shah SJ, Levine LA. Verapamil versus saline in electromotive drug administration for Peyronie’s disease: a double-blind, placebo controlled trial. J Urol. 2007;177(3):972–5.

    Article  PubMed  CAS  Google Scholar 

  17. Hellstrom WJ, Kendirci M, Matern R, Cockerham Y, et al. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie’s disease. J Urol. 2006;176(1):394–8.

    Article  PubMed  CAS  Google Scholar 

  18. Kendirci M, Usta MF, Matern RV, Nowfar S, et al. The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie’s disease. J Sex Med. 2005;2(5):709–15.

    Article  PubMed  CAS  Google Scholar 

  19. Vardi Y, Levine LA, Chen J, Hatzimouratidis K, Sohn M. Is there a place for conservative treatment in Peyronie’s disease? J Sex Med. 2009;6(4):903–9.

    Article  PubMed  Google Scholar 

  20. De Berardinis E, Busetto GM, Antonini G, Giovannone R, Gentile V. Extracorporeal shock wave therapy in the treatment of Peyronie’s disease: long-term results. Arch Ital Urol Androl. 2010;82(2):128–33.

    PubMed  Google Scholar 

  21. Chitale S, Morsey M, Swift L, Sethia K. Limited shock wave therapy vs. sham treatment in men with Peyronie’s disease: results of a prospective randomized controlled double-blind trial. BJU Int. 2010;106(9):1352–6.

    Article  PubMed  Google Scholar 

  22. Rahim AA, Giraffe G, Rahim TA, Dixon M, et al. The role of vacuum pump therapy to mechanically straighten the penis in Peyronie’s disease. BJU Int. 2010;106(8):1178–80.

    Article  Google Scholar 

  23. Levine LA, Newell M, Taylor FL. Penile traction therapy for treatment of Peyronie’s disease: a single-center pilot study. J Sex Med. 2008;5(6):1468–73.

    Article  PubMed  Google Scholar 

  24. Mulhall J, Anderson M, Parker M. A surgical algorithm for men with combined Peyronie’s disease and erectile dysfunction: functional and satisfaction outcomes. J Sex Med. 2005;2(1):132–8.

    Article  PubMed  Google Scholar 

  25. Richardson B, Pinsk MR, Hellstrom WJ. Incision and grafting for severe Peyronie’s disease. J Sex Med. 2009;6(8):2084–7.

    Article  PubMed  Google Scholar 

  26. Lentz AC, Carson 3rd CC. Peyronie’s surgery: graft choices and outcomes. Curr Urol Rep. 2009;10(6): 460–7.

    Article  PubMed  Google Scholar 

  27. Chung E, Clendenin E, Lesser L, Brock G. Five-year follow-up of Peyronie’s graft surgery: outcomes and patient satisfaction. J Sex Med. 2011;8(2):594–600.

    Article  PubMed  Google Scholar 

  28. Levine LA, Demetrious RJ. A surgical algorithm for penile prosthesis placement in men with erectile failure and Peyronie’s disease. Int J Impot Res. 2000; 12(3):147–51.

    Article  PubMed  CAS  Google Scholar 

  29. Levine LA, Benso J, Hoover C. Inflatable penile prosthesis placement in men with Peyronie’s disease and drug-resistant erectile dysfunction: a single-center study. J Sex Med. 2010;7(11):3775–83.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd., Weston, FL, 33331, USA

    Lawrence S. Hakim MD, FACS

Authors
  1. Lawrence S. Hakim MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lawrence S. Hakim MD, FACS .

Editor information

Editors and Affiliations

  1. The Glickman Urologic and, Kidney Institute, Department of Urology, Cleveland, 44195, Ohio, USA

    Daniel A. Shoskes

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hakim, L.S. (2012). Evaluation and Treatment of Peyronie’s Disease. In: Shoskes, D. (eds) Urological Men’s Health. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-900-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-900-6_10

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-899-3

  • Online ISBN: 978-1-61779-900-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation